研究动态
Articles below are published ahead of final publication in an issue. Please cite articles in the following format: authors, (year), title, journal, DOI.

在儿科初级保健诊所中推行提高人乳头瘤病毒二针疫苗接种率的质量改进项目,目标是增加13岁儿童的接种完成率。

Quality Improvement Project to Increase Human Papillomavirus Two-Dose Vaccine Series Completion by 13 Years in Pediatric Primary Care Clinics.

发表日期:2023 Mar 14
作者: Amina Smajlovic, Christina D Toth
来源: Immunity & Ageing

摘要:

人类乳头瘤病毒(HPV)会导致泌尿生殖系统和口咽部癌症。HPV疫苗可以有效地预防这些疾病并且非常安全,但是在美国,疫苗接种系列完成率仍然很低。我们的质量改进(QI)项目旨在提高13岁患者人群在俄亥俄州哥伦布市一个专门为少数民族和医疗保险儿童服务的广泛学术儿科初级保健网络中的HPV疫苗接种系列完成率,从2017年到2020年将其提高到70%。结果措施是以13岁的孩子生日为截止日期,完成了两剂疫苗系列的全国儿童医院初级保健网络患者的百分比。我们采用了四种质量改进措施。电子病历警报通知提供者HPV疫苗的接种时间。我们使用统计过程控制研究网络和个别诊所的每月数据,将数据显示在控制图上。我们遵循了二个过程措施,即机会率和HPV疫苗接种次数。我们将13岁青少年人群中HPV疫苗接种系列完成率从27%显著提高到65%,其中3个诊所至少有一个季度达到了70%的目标。拉丁裔儿童的完成率最高,达到了80%,而白人儿童的完成率最低,只有64%。我们的QI项目采用了4种措施来提高为少数民族和低收入青少年提供服务的13岁患者人群中的HPV疫苗接种系列完成率。需要进行进一步的QI研究以提高青少年的HPV疫苗接种完成率。Copyright © 2023 Society for Adolescent Health and Medicine. Published by Elsevier Inc. All rights reserved.
The human papillomavirus (HPV) causes genitourinary and oropharyngeal cancers. The HPV vaccine is safe and effective in preventing those diseases; however, vaccine series completion rates remain low in the United States. Our quality improvement (QI) project aimed to increase HPV-vaccination series completion rates to 70% from 2017 to 2020 for the 13-year patient population in an extensive academic pediatric primary care network that serves predominantly minority and Medicaid-insured children in Columbus, OH.The outcome measure was the percentage of 13-years Nationwide Children's Hospital Primary Care Network patients who completed the two-dose vaccine series by their 13th birthday. Four QI implemented interventions were utilized. Electronic medical records alert informed providers when the HPV vaccines are due. We studied monthly data for the network and for individual clinics using statistical process control, displaying data on a control chart. We followed two process measures, captured opportunity rate, and the number of HPV vaccines given.We substantially increased HPV-vaccination series completion rates overall in the 13-year teen population from 27% to 65%, and three clinics reached the 70% goal for at least one quarter. Latino children had the highest completion rate of 80% and White children had the lowest completion rate at 64%.Our QI project used four measures to improve HPV-vaccination series completion rates in the 13-year patient population that serves minority and low-income teens predominantly. Further QI studies are needed to improve HPV vaccine completion rates in teens.Copyright © 2023 Society for Adolescent Health and Medicine. Published by Elsevier Inc. All rights reserved.